(
58.2 mg), which was purified on a silica gel column (200–300
Material and Methods
mesh, CHCl /MeOH, 50:1, v/v), to give compound 14 (16.0 mg).
3
Subfraction IV2.4 (300 mg) was subjected to Sephadex LH-20 CC
General experimental procedures
(
CHCl /MeOH, 1:1, v/v) to provide compound 5 (6.1 mg). Sub-
3
Silica gel (100–200, 200–300 mesh; Qingdao Marine Chemical,
Inc.), MCI gel (75–150 µm; Mitsubishi Chemical Corporation), RP-
fraction IV2.5 (1.9 g) was separated by silica gel CC (200–300
mesh) with petroleum ether/acetone (5:1, v/v) to afford eight
subfractions, IV2.5.1~IV2.5.6. Compounds 6 (5.0 mg, tR 29.7 min)
and 8 (7.0 mg, tR 24.5 min) were obtained from subfraction
1
2
8 reverse-phase silica gel (40–63 µm; Merck), and Sephadex LH-
0 were used for column chromatography (CC). Semipreparative
HPLC was performed on an Agilent 1260 liquid chromatograph
equipped with an Eclipse XDB‑C18 (9.4 × 250 mm, 5 µm) column.
IR spectra were measured on a Bio-Rad FTS-135 spectrometer
with KBr pellets. UV spectra were recorded using a Shimadzu UV-
IV2.5.4 by semipreparative HPLC with MeOH/H O (43:57, v/v) at
2
a flow rate of 3 mL/min. Subfraction IV2.5.5 (185 mg) was purified
by Sephadex LH-20 CC with MeOH to yield compound 4 (8.2 mg).
Subfraction IV2.6 (2.5 g) was purified by Sephadex LH-20 CC
2
401A spectrophotometer. Optical rotations were obtained on a
(MeOH), followed by semipreparative HPLC (MeOH/H O, 47 : 53,
2
Horiba SEPA-300 high sensitivity polarimeter. NMR spectra were
recorded on Bruker AM-400 spectrometers with TMS as an inter-
nal standard. HRESIMS was measured using an Agilent 1290 UPLC/
v/v, flow rate of 3 mL/min) to give compounds 2 (11.1 mg, tR
29.1 min) and 3 (5.3 mg, tR 30.6 min). Subfraction IV2.7 (1.5 g)
was subjected to RP-18 CC (MeOH/H O, 40:60, 60:40, 80:20,
2
6
540 Q‑TOF instrument. The α-glucosidase from Saccharomyces
100:0, v/v), followed by Sephadex LH-20 CC (MeOH) to yield
cerevisiae from Sigma-Aldrich Trading Co. Ltd., acarbose from J&K
China Chemical Ltd., and PNPG from Sigma-Aldrich Trading Co.
Ltd. were used in the bioactivity assay.
compound 10 (8.9 mg). Subfraction IV (496 mg) was subjected
to Sephadex LH-20 CC with MeOH elution to yield a fraction
(95.2 mg), which was purified on semipreparative HPLC with
4
MeOH/H O (54:46, v/v) at a flow rate of 3 mL/min, to give com-
pound 13 (16.0 mg, tR 32.3 min). Subfraction IV5 (30.5 g) was
2
Plant material
Aerial parts and roots of H. heterophyllum were collected in
Chuxiong City, Yunnan province, P. R. China, in July 2016. The
plant material was authenticated by Prof. Qing-Song Yang at the
Yunnan Minzu University. A voucher specimen (No. 2016-07-23)
was deposited at the Key Laboratory of Chemistry in Ethnic Medic-
inal Resources, State Ethnic Affairs Commission & Ministry of Edu-
cation, School of Ethnomedicine and Ethnopharmacy, Yunnan
Minzu University.
chromatographed on an MCI gel column with MeOH/H O
2
(30:70, 60:40, 90:10, 100:0, v/v) to yield eight subfractions,
IV5.1~IV5.9. Compound 15 (12.0 mg, tR 35.6 min) was isolated
from subfraction IV5.5 (33.0 mg) by semipreparative HPLC with
MeOH/H O (58:42, v/v) at a flow rate of 3 mL/min. Subfraction
2
IV5.6 (408 mg) was subjected to Sephadex LH-20 CC with MeOH
to provide compound 12 (6.0 mg).
2
5
Heterophoside A (1): Off-white amorphous powder; [α]
D
− 36.8
(
3
c 0.17, MeOH); UV (MeOH) λmax (log ε): 212 (4.71), 225 (4.78),
Extraction and isolation
13 (4.86) nm; IR (KBr) υmax: 3434, 2026, 1638, 1443, 1076,
−
1
1
The air-dried whole plants (20.0 kg) of H. heterophyllum were pow-
dered and extracted three times with 95% EtOH (60 L) at room
temperature for 48 h. The three extracts were combined and con-
centrated under reduced pressure to give a sticky residue (3.8 kg).
The residue was suspended in water (4 L) and then partitioned se-
quentially with petroleum ether (6 × 5 L), EtOAc (6 × 5 L), and n-
BuOH (6 × 5 L). The EtOAc-soluble fraction (2.0 kg) was fraction-
ated in two portions on a silica gel column (100–200 mesh,
859, 546 cm ; For H NMR (CD OD, 400 MHz) and 13C NMR
(CD OD, 100 MHz) spectroscopic data, see ▶ Table 1; HRESIMS
3
3
+
m/z: 469.1470 [M + Na] (calcd. for C23H26NaO , 469.1475).
9
2
5
Heterophoside B (2): Off-white amorphous powder; [α]
D
− 34.2
(c 0.22, MeOH); UV (MeOH) λmax (log ε): 201 (5.08), 288 (4.64),
326 (4.78) nm; IR (KBr) υ : 3435, 2026, 1651, 1444, 1269,
1121, 1072, 859, 545 cm ; For H NMR (CD OD, 400 MHz) and
1
max
−
1
1
3
3
C NMR (CD OD, 100 MHz) spectroscopic data, see ▶ Table 1;
3
1
9
5 × 120 cm) eluted with a CHCl /MeOH gradient system (10:0,
:1, 8:2, 7:3, 6:4, 5:5, 0:10, v/v; collection size: 1000 mL) to
HRESIMS m/z: 529.1685 [M + Na]+ (calcd. for C25H30NaO11
529.1686).
,
3
2
5
yield five fractions (Frs I~V) after TLC analysis.
Heterophoside C (3): Off-white amorphous powder; [α]
D
− 23.5
Fraction IV (545 g), with moderate α-glucosidase inhibitory ac-
tivity (IC50 = 172.1 µg/mL), was fractionated by silica gel CC (200–
(c 0.10, MeOH); UV (MeOH) λmax (log ε): 204 (5.58), 288 (4.99),
326 (5.14) nm; IR (KBr) υ : 3431, 2027, 1657, 1442, 1270,
max
1117, 857, 545 cm ; For H NMR (CD OD, 400 MHz) and 13C
−
1
1
3
00 mesh) with CHCl /MeOH (50:1, 30:1, 10:1, 5:5, 0:1, v/v) to
3
3
provide subfractions IV ~IV . Subfraction IV (6.0 g) was sub-
NMR (CD OD, 100 MHz) spectroscopic data, see ▶ Table 1;
3
1
7
1
jected to silica gel CC (200–300 mesh, CHCl /MeOH, 50:1, v/v)
HRESIMS m/z: 529.1685 [M + Na]+ (calcd. for C25H30NaO11
,
3
to yield a fraction (310 mg), which was purified by semiprepara-
529.1687).
2
5
tive HPLC (MeOH/H O, 60:40, v/v, flow rate of 3 mL/min), to yield
Piscroside D (11): White amorphous powder; [α]
0.20, CHCl ); UV (MeOH) λ
D
− 48.3 (c
2
compound 11 (10.0 mg, t 23.7 min). Subfraction IV (38.0 g) was
(log ε): 283 (4.72) nm; IR (KBr)
max
R
2
3
−
1
chromatographed by MCI gel CC with MeOH/H O (0:100, 50:50,
υmax: 3441, 2326, 1655, 1424, 1263, 1120, 1066, 863, 544 cm ;
2
1
13
7
0:30, 90:10, 100:0, v/v) to yield eight subfractions, IV2.1~IV2.9
.
For H NMR (CD OD, 400 MHz) and C NMR (CD OD, 100 MHz)
3 3
Subfraction IV2.2 (2.2 g) was purified by Sephadex LH-20 CC
spectroscopic data, see ▶ Table 2; HRESIMS m/z: 559.1591 [M +
Cl] (calcd. for C25H32ClO12, 559.1582).
−
(
(
CHCl /MeOH, 1:1, v/v) to furnish compounds 1 (9.5 mg), 7
23.5 mg), and 9 (12.0 mg). Subfraction IV2.3 (897 mg) was sub-
3
jected to Sephadex LH-20 CC with MeOH to yield a fraction
Li YH et al. Phenylpropanoid and Iridoid … Planta Med